3-N-Butylphthalide
Butylphthalide may increase the anticoagulant activities of Clopidogrel.
Abciximab
Clopidogrel may increase the anticoagulant activities of Abciximab.
Abiraterone
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Abiraterone resulting in a loss in efficacy.
Advertisement
Acenocoumarol
Clopidogrel may increase the anticoagulant activities of Acenocoumarol.
Acetyl salicylate
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Acetylsalicylic acid.
Acetyl Sulfisoxazole
The metabolism of Clopidogrel can be decreased when combined with Acetyl sulfisoxazole.
Advertisement
Aloxiprin
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Aloxiprin.
alpha Tocopherol
Vitamin E may increase the antiplatelet activities of Clopidogrel.
Alprostadil
Alprostadil may increase the anticoagulant activities of Clopidogrel.
Advertisement
Alteplase
Clopidogrel may increase the anticoagulant activities of Alteplase.
Aminosalicylic Acid
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Aminosalicylic Acid.
Amiodarone
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Amiodarone.
Amitriptyline
The metabolism of Amitriptyline can be decreased when combined with Clopidogrel.
Amlodipine
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Amlodipine.
Amodiaquine
The serum concentration of Amodiaquine can be increased when it is combined with Clopidogrel.
Anagrelide
Clopidogrel may increase the anticoagulant activities of Anagrelide.
Ancrod
Clopidogrel may increase the anticoagulant activities of Ancrod.
Anistreplase
Clopidogrel may increase the anticoagulant activities of Anistreplase.
Antipyrine
The metabolism of Antipyrine can be decreased when combined with Clopidogrel.
Antithrombin III
Clopidogrel may increase the anticoagulant activities of Antithrombin III human.
Antithrombin III, Human
Clopidogrel may increase the anticoagulant activities of Antithrombin III human.
Apalutamide
The serum concentration of Clopidogrel can be decreased when it is combined with Apalutamide.
Apixaban
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Apixaban.
Aprepitant
The serum concentration of Clopidogrel can be increased when it is combined with Aprepitant.
Aprotinin
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Aprotinin.
Ardeparin
Clopidogrel may increase the anticoagulant activities of Ardeparin.
Argatroban
Clopidogrel may increase the anticoagulant activities of Argatroban.
Argatroban Anhydrous
Clopidogrel may increase the anticoagulant activities of Argatroban.
Armodafinil
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Armodafinil resulting in a loss in efficacy.
Artemether
The metabolism of Artemether can be decreased when combined with Clopidogrel.
Aspirin
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Acetylsalicylic acid.
Astaxanthin
Clopidogrel may increase the anticoagulant activities of Astaxanthin.
Asunaprevir
The metabolism of Asunaprevir can be decreased when combined with Clopidogrel.
Atazanavir
The metabolism of Clopidogrel can be decreased when combined with Atazanavir.
Atomoxetine
The metabolism of Clopidogrel can be decreased when combined with Atomoxetine.
Azelastine
Azelastine may increase the anticoagulant activities of Clopidogrel.
Azithromycin
The metabolism of Clopidogrel can be decreased when combined with Azithromycin.
Balsalazide
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Balsalazide.
Becaplermin
Clopidogrel may increase the anticoagulant activities of Becaplermin.
Bemiparin
Clopidogrel may increase the anticoagulant activities of Bemiparin.
Bencyclane
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Bencyclane.
Benzphetamine
The metabolism of Benzphetamine can be decreased when combined with Clopidogrel.
Benzyl Alcohol
The metabolism of Benzyl alcohol can be decreased when combined with Clopidogrel.
Bepridil
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Bepridil.
Bioallethrin
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Bioallethrin.
Bivalirudin
Clopidogrel may increase the anticoagulant activities of Bivalirudin.
Boceprevir
The metabolism of Clopidogrel can be decreased when combined with Boceprevir.
Bortezomib
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Bortezomib resulting in a loss in efficacy.
Bosentan
The serum concentration of Clopidogrel can be decreased when it is combined with Bosentan.
Bosentan Anhydrous
The serum concentration of Clopidogrel can be decreased when it is combined with Bosentan.
Brivaracetam
The metabolism of Brivaracetam can be decreased when combined with Clopidogrel.
Brompheniramine
The metabolism of Brompheniramine can be decreased when combined with Clopidogrel.
Bupropion
The serum concentration of Bupropion can be increased when it is combined with Clopidogrel.
Caffeine
The metabolism of Clopidogrel can be decreased when combined with Caffeine.
Cangrelor
Cangrelor may decrease the antiplatelet activities of Clopidogrel.
Capecitabine
The metabolism of Clopidogrel can be decreased when combined with Capecitabine.
Carbamazepine
The metabolism of Clopidogrel can be increased when combined with Carbamazepine.
Carbinoxamine
The metabolism of Carbinoxamine can be decreased when combined with Clopidogrel.
Ceritinib
The serum concentration of Clopidogrel can be increased when it is combined with Ceritinib.
Cerivastatin
The risk or severity of rhabdomyolysis can be increased when Clopidogrel is combined with Cerivastatin.
Certoparin
Clopidogrel may increase the anticoagulant activities of Certoparin.
Chloramphenicol
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Chloramphenicol resulting in a loss in efficacy.
Chlormethiazole
The metabolism of clomethiazole can be decreased when combined with Clopidogrel.
Cholecalciferol
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Cholecalciferol resulting in a loss in efficacy.
Cilostazol
Clopidogrel may increase the anticoagulant activities of Cilostazol.
Cimetidine
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Cimetidine resulting in a loss in efficacy.
Cinnarizine
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Cinnarizine.
Cisapride
The metabolism of Cisapride can be decreased when combined with Clopidogrel.
Citalopram
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Citalopram resulting in a loss in efficacy.
Citric Acid
Clopidogrel may increase the anticoagulant activities of Citric Acid.
Citric Acid, Anhydrous
Clopidogrel may increase the anticoagulant activities of Citric Acid.
Clarithromycin
The metabolism of Clopidogrel can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Clopidogrel can be decreased when combined with Clemastine.
Clevidipine
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Clevidipine.
Clevidipine butyrate
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Clevidipine.
Clobazam
The metabolism of Clobazam can be decreased when combined with Clopidogrel.
Clofezone
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Rabeprazole resulting in a loss in efficacy.
Clotiazepam
The metabolism of Clotiazepam can be decreased when combined with Clopidogrel.
Clotrimazole
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Clotrimazole resulting in a loss in efficacy.
Cobicistat
The metabolism of Clopidogrel can be decreased when combined with Cobicistat.
COLLAGENASE
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Collagenase clostridium histolyticum.
collagenase Clostridium histolyticum
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Collagenase clostridium histolyticum.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Clopidogrel.
Crisaborole
The metabolism of Clopidogrel can be decreased when combined with Crisaborole.
Crizotinib
The metabolism of Clopidogrel can be decreased when combined with Crizotinib.
Curcumin
The metabolism of Clopidogrel can be decreased when combined with Curcumin.
Cyclandelate
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Cyclandelate.
Cyclophosphamide
The metabolism of Cyclophosphamide can be decreased when combined with Clopidogrel.
Cyclophosphamide Anhydrous
The metabolism of Cyclophosphamide can be decreased when combined with Clopidogrel.
Cyclosporine
The metabolism of Clopidogrel can be decreased when combined with Cyclosporine.
Cyproterone Acetate
The serum concentration of Clopidogrel can be decreased when it is combined with Cyproterone acetate.
Dabigatran Etexilate
Clopidogrel may increase the anticoagulant activities of Dabigatran etexilate.
Dabrafenib
The serum concentration of Clopidogrel can be decreased when it is combined with Dabrafenib.
Dalteparin
Clopidogrel may increase the anticoagulant activities of Dalteparin.
Danaparoid
Clopidogrel may increase the anticoagulant activities of Danaparoid.
Darunavir
The metabolism of Clopidogrel can be decreased when combined with Darunavir.
Dasatinib
Dasatinib may increase the anticoagulant activities of Clopidogrel.
Dasatinib Anhydrous
Dasatinib may increase the anticoagulant activities of Clopidogrel.
Deferasirox
The serum concentration of Clopidogrel can be decreased when it is combined with Deferasirox.
Defibrotide
Clopidogrel may increase the anticoagulant activities of Defibrotide.
Delavirdine
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Delavirdine resulting in a loss in efficacy.
Deoxycholate
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Deoxycholic Acid.
Deoxycholic Acid
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Deoxycholic Acid.
Desipramine
The metabolism of Clopidogrel can be decreased when combined with Desipramine.
Desirudin
Clopidogrel may increase the anticoagulant activities of Desirudin.
Dexlansoprazole
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Dexlansoprazole resulting in a loss in efficacy.
Dextran
Clopidogrel may increase the anticoagulant activities of Dextran.
Dextromethorphan
The metabolism of Dextromethorphan can be decreased when combined with Clopidogrel.
Diazepam
The metabolism of Diazepam can be decreased when combined with Clopidogrel.
Diclofenac
The metabolism of Diclofenac can be decreased when combined with Clopidogrel.
Dicumarol
Clopidogrel may increase the anticoagulant activities of Dicoumarol.
Diflunisal
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Diflunisal.
Dihydroergotamine
The metabolism of Clopidogrel can be decreased when combined with Dihydroergotamine.
Diltiazem
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Diltiazem.
Diphenhydramine
The metabolism of Diphenhydramine can be decreased when combined with Clopidogrel.
Dipyridamole
Dipyridamole may increase the anticoagulant activities of Clopidogrel.
Domperidone
The metabolism of Domperidone can be decreased when combined with Clopidogrel.
Dothiepin
The metabolism of Clopidogrel can be decreased when combined with Dosulepin.
Doxorubicin
The metabolism of Clopidogrel can be decreased when combined with Doxorubicin.
Doxorubicin Hydrochloride
The metabolism of Clopidogrel can be decreased when combined with Doxorubicin.
Doxycycline
The metabolism of Clopidogrel can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Clopidogrel can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Clopidogrel can be decreased when combined with Dronedarone.
Drotrecogin Alfa
Clopidogrel may increase the anticoagulant activities of Drotrecogin alfa.
Edetic Acid
Clopidogrel may increase the anticoagulant activities of Edetic Acid.
Edoxaban
Clopidogrel may increase the anticoagulant activities of Edoxaban.
Efavirenz
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Efavirenz resulting in a loss in efficacy.
Enasidenib
The metabolism of Enasidenib can be decreased when combined with Clopidogrel.
Enoxaparin
Clopidogrel may increase the anticoagulant activities of Enoxaparin.
Enoxaparin sodium
Clopidogrel may increase the anticoagulant activities of Enoxaparin.
Enzalutamide
The serum concentration of Clopidogrel can be decreased when it is combined with Enzalutamide.
Epinastine
The metabolism of Epinastine can be decreased when combined with Clopidogrel.
Epoprostenol
Clopidogrel may increase the anticoagulant activities of Epoprostenol.
Eptifibatide
Eptifibatide may increase the anticoagulant activities of Clopidogrel.
Erythromycin
Erythromycin may decrease the antiplatelet activities of Clopidogrel.
Eslicarbazepine Acetate
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Eslicarbazepine acetate resulting in a loss in efficacy.
Esomeprazole
Esomeprazole may decrease the antiplatelet activities of Clopidogrel.
Estrone
The metabolism of Estrone can be decreased when combined with Clopidogrel.
Ethosuximide
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Ethosuximide.
Ethylenediaminetetraacetate
Clopidogrel may increase the anticoagulant activities of Edetic Acid.
Ethylmorphine
The metabolism of Ethylmorphine can be decreased when combined with Clopidogrel.
Etravirine
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Etravirine resulting in a loss in efficacy.
Felodipine
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Felodipine.
Fendiline
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Fendiline.
Ferulic Acid
Clopidogrel may increase the anticoagulant activities of Ferulic acid.
Fibrinolysis Inhibitor
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Aprotinin.
Fish Oils
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Fish oil.
Floxuridine
The metabolism of Clopidogrel can be decreased when combined with Floxuridine.
Fluconazole
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Fluconazole resulting in a loss in efficacy.
Fluindione
Clopidogrel may increase the anticoagulant activities of Fluindione.
Flunarizine
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Flunarizine.
Flunitrazepam
The metabolism of Flunitrazepam can be decreased when combined with Clopidogrel.
Fluorouracil
The metabolism of Clopidogrel can be decreased when combined with Fluorouracil.
Fluoxetine
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Fluoxetine resulting in a loss in efficacy.
Fluspirilene
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Fluspirilene.
Fluvastatin
The metabolism of Clopidogrel can be decreased when combined with Fluvastatin.
Fluvoxamine
The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Clopidogrel.
Fondaparinux sodium
Clopidogrel may increase the anticoagulant activities of Fondaparinux sodium.
Fosamprenavir
The metabolism of Clopidogrel can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Clopidogrel can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Clopidogrel can be increased when combined with Fosphenytoin.
Fusidate
The serum concentration of Clopidogrel can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Clopidogrel can be increased when it is combined with Fusidic Acid.
Gabapentin
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Gabapentin.
Gallopamil
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Gallopamil.
Gemfibrozil
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Gemfibrozil resulting in a loss in efficacy.
Glucosamine
Glucosamine may increase the antiplatelet activities of Clopidogrel.
Halothane
The metabolism of Halothane can be decreased when combined with Clopidogrel.
Heparin
Clopidogrel may increase the anticoagulant activities of Heparin.
Hydroxytyrosol
Hydroxytyrosol may increase the anticoagulant activities of Clopidogrel.
Hypoxis hemerocallidea root extract
The serum concentration of Clopidogrel can be decreased when it is combined with St. John's Wort.
Ibritumomab Tiuxetan
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Ibritumomab tiuxetan.
Ibrutinib
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Clopidogrel.
Icosapent Ethyl
Icosapent ethyl may increase the anticoagulant activities of Clopidogrel.
Idelalisib
The metabolism of Clopidogrel can be decreased when combined with Idelalisib.
Ifenprodil
Ifenprodil may increase the anticoagulant activities of Clopidogrel.
Ifosfamide
The metabolism of Ifosfamide can be decreased when combined with Clopidogrel.
Iloprost
Clopidogrel may increase the anticoagulant activities of Iloprost.
Imatinib
The metabolism of Clopidogrel can be decreased when combined with Imatinib.
Imipramine
The metabolism of Imipramine can be decreased when combined with Clopidogrel.
Inamrinone
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Amrinone.
Indinavir
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Indinavir resulting in a loss in efficacy.
INDINAVIR ANHYDROUS
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Indinavir resulting in a loss in efficacy.
Indobufen
Clopidogrel may increase the anticoagulant activities of Indobufen.
Irbesartan
The metabolism of Clopidogrel can be decreased when combined with Irbesartan.
Irinotecan
The metabolism of Irinotecan can be decreased when combined with Clopidogrel.
Isavuconazole
The serum concentration of Clopidogrel can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Clopidogrel can be decreased when combined with Isavuconazonium.
Isoflurane
The metabolism of Isoflurane can be decreased when combined with Clopidogrel.
Isoniazid
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Isoniazid resulting in a loss in efficacy.
Isradipine
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Isradipine.
Itraconazole
The metabolism of Clopidogrel can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Clopidogrel can be increased when it is combined with Ivacaftor.
Ixazomib
The metabolism of Ixazomib can be decreased when combined with Clopidogrel.
Ketamine
The metabolism of Ketamine can be decreased when combined with Clopidogrel.
Ketanserin
Ketanserin may increase the anticoagulant activities of Clopidogrel.
Ketoconazole
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Ketoconazole resulting in a loss in efficacy.
Lacidipine
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Lacidipine.
Lamotrigine
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Lamotrigine.
Lansoprazole
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Lansoprazole resulting in a loss in efficacy.
Leflunomide
The metabolism of Clopidogrel can be decreased when combined with Leflunomide.
Lepirudin
Clopidogrel may increase the anticoagulant activities of Lepirudin.
Lercanidipine
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Lercanidipine.
Levetiracetam
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Levetiracetam.
LEVOMENTHOL
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Menthol.
Lidocaine
The metabolism of Clopidogrel can be decreased when combined with Lidocaine.
Loperamide
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Loperamide.
Lopinavir
The metabolism of Clopidogrel can be decreased when combined with Lopinavir.
Lorcaserin
The metabolism of Lorcaserin can be decreased when combined with Clopidogrel.
Losartan
The metabolism of Clopidogrel can be decreased when combined with Losartan.
Lovastatin
The metabolism of Clopidogrel can be decreased when combined with Lovastatin.
Luliconazole
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Luliconazole resulting in a loss in efficacy.
Lumacaftor
The serum concentration of Clopidogrel can be decreased when it is combined with Lumacaftor.
Magnesium Sulfate
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Magnesium sulfate.
Malathion
The metabolism of Malathion can be decreased when combined with Clopidogrel.
Manidipine
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Manidipine.
Menthol
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Menthol.
Meperidine
The metabolism of Pethidine can be decreased when combined with Clopidogrel.
Mephenytoin
The metabolism of Mephenytoin can be decreased when combined with Clopidogrel.
Mephobarbital
The metabolism of Methylphenobarbital can be decreased when combined with Clopidogrel.
Mepirodipine
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Barnidipine.
Mesalamine
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Mesalazine.
Methadone
The metabolism of Methadone can be decreased when combined with Clopidogrel.
Methoxyflurane
The metabolism of Methoxyflurane can be decreased when combined with Clopidogrel.
Methsuximide
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Methsuximide.
Methyl Salicylate
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Methyl salicylate.
Methyltestosterone
The metabolism of Methyltestosterone can be decreased when combined with Clopidogrel.
Mexiletine
The metabolism of Clopidogrel can be decreased when combined with Mexiletine.
Mianserin
The metabolism of Mianserin can be decreased when combined with Clopidogrel.
Mibefradil
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Mibefradil.
Midazolam
The metabolism of Midazolam can be decreased when combined with Clopidogrel.
Midostaurin
The metabolism of Clopidogrel can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Clopidogrel can be increased when it is combined with Mifepristone.
Milrinone
Milrinone may increase the anticoagulant activities of Clopidogrel.
Mitotane
The serum concentration of Clopidogrel can be decreased when it is combined with Mitotane.
Moclobemide
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Moclobemide resulting in a loss in efficacy.
Modafinil
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Modafinil resulting in a loss in efficacy.
Morphine
Morphine may decrease the antiplatelet activities of Clopidogrel.
Nabilone
The metabolism of Clopidogrel can be decreased when combined with Nabilone.
Nadroparin
Clopidogrel may increase the anticoagulant activities of Nadroparin.
Nefazodone
The metabolism of Clopidogrel can be decreased when combined with Nefazodone.
Nelfinavir
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Nelfinavir resulting in a loss in efficacy.
Netupitant
The serum concentration of Clopidogrel can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Clopidogrel can be increased when combined with Nevirapine.
Nicardipine
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Nicardipine resulting in a loss in efficacy.
Nicotine
The metabolism of Nicotine can be decreased when combined with Clopidogrel.
Nicotine Polacrilex
The metabolism of Nicotine can be decreased when combined with Clopidogrel.
Nifedipine
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Nifedipine.
Nilotinib
The metabolism of Clopidogrel can be decreased when combined with Nilotinib.
Nilvadipine
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Nilvadipine.
Nimesulide
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Nimesulide.
Nimodipine
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Nimodipine.
Nisoldipine
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Nisoldipine.
Nitrendipine
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Nitrendipine.
Nylidrin
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Nylidrin.
Obinutuzumab
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Obinutuzumab.
Octylonium
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Otilonium.
Olaparib
The metabolism of Clopidogrel can be decreased when combined with Olaparib.
Olsalazine
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Olsalazine.
Omega-3 Fatty Acids
Omega-3 fatty acids may increase the antiplatelet activities of Clopidogrel.
Omeprazole
Omeprazole may decrease the antiplatelet activities of Clopidogrel.
Osimertinib
The serum concentration of Clopidogrel can be increased when it is combined with Osimertinib.
Ospemifene
The metabolism of Ospemifene can be decreased when combined with Clopidogrel.
Palbociclib
The serum concentration of Clopidogrel can be increased when it is combined with Palbociclib.
Pantoprazole
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Pantoprazole resulting in a loss in efficacy.
Paregoric
Morphine may decrease the antiplatelet activities of Clopidogrel.
Parnaparin
Clopidogrel may increase the anticoagulant activities of Parnaparin.
Paroxetine
The metabolism of Clopidogrel can be decreased when combined with Paroxetine.
Peginterferon Alfa-2b
The serum concentration of Clopidogrel can be increased when it is combined with Peginterferon alfa-2b.
Pentaerythritol Tetranitrate
Clopidogrel may increase the anticoagulant activities of Pentaerythritol Tetranitrate.
Pentobarbital
The metabolism of Clopidogrel can be increased when combined with Pentobarbital.
Pentosan Polysulfate
The risk or severity of adverse effects can be increased when Pentosan Polysulfate is combined with Clopidogrel.
Pentoxifylline
Pentoxifylline may increase the antiplatelet activities of Clopidogrel.
Perhexiline
The metabolism of Perhexiline can be decreased when combined with Clopidogrel.
Permethrin
The metabolism of Permethrin can be decreased when combined with Clopidogrel.
Perphenazine
The metabolism of Perphenazine can be decreased when combined with Clopidogrel.
Phenindione
Clopidogrel may increase the anticoagulant activities of Phenindione.
Phenobarbital
The metabolism of Clopidogrel can be increased when combined with Phenobarbital.
Phenprocoumon
Clopidogrel may increase the anticoagulant activities of Phenprocoumon.
Phenytoin
The metabolism of Clopidogrel can be increased when combined with Phenytoin.
Phospholipids
Omega-3 fatty acids may increase the antiplatelet activities of Clopidogrel.
Pinaverium
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Pinaverium.
Plasmin
Clopidogrel may increase the anticoagulant activities of Fibrinolysin.
Posaconazole
The metabolism of Clopidogrel can be decreased when combined with Posaconazole.
Potassium Citrate
Clopidogrel may increase the anticoagulant activities of Potassium Citrate.
Prasugrel
The metabolism of Prasugrel can be decreased when combined with Clopidogrel.
Prenylamine
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Prenylamine.
Primidone
The metabolism of Clopidogrel can be increased when combined with Primidone.
Promethazine
The metabolism of Promethazine can be decreased when combined with Clopidogrel.
Propofol
The metabolism of Propofol can be decreased when combined with Clopidogrel.
protein C, human
Clopidogrel may increase the anticoagulant activities of Protein C.
protein S, human
Clopidogrel may increase the anticoagulant activities of Protein S human.
Protocatechualdehyde
Clopidogrel may increase the anticoagulant activities of Protocatechualdehyde.
Pyrimethamine
The metabolism of Clopidogrel can be decreased when combined with Pyrimethamine.
Quazepam
The serum concentration of Clopidogrel can be increased when it is combined with Quazepam.
Quinine
The metabolism of Clopidogrel can be decreased when combined with Quinine.
Rabeprazole
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Rabeprazole resulting in a loss in efficacy.
Ranolazine
The serum concentration of Clopidogrel can be increased when it is combined with Ranolazine.
Repaglinide
The serum concentration of Repaglinide can be increased when it is combined with Clopidogrel.
Resveratrol
Resveratrol may increase the anticoagulant activities of Clopidogrel.
Reteplase
Clopidogrel may increase the anticoagulant activities of Reteplase.
Reviparin
Clopidogrel may increase the anticoagulant activities of Reviparin.
Reviparin sodium
Clopidogrel may increase the anticoagulant activities of Reviparin.
Rifabutin
The risk or severity of adverse effects can be increased when Rifabutin is combined with Clopidogrel.
Rifampin
The risk or severity of adverse effects can be increased when Rifampicin is combined with Clopidogrel.
Rifapentine
The risk or severity of adverse effects can be increased when Rifapentine is combined with Clopidogrel.
Rifaximin
The risk or severity of adverse effects can be increased when Rifaximin is combined with Clopidogrel.
Ritonavir
The metabolism of Ritonavir can be decreased when combined with Clopidogrel.
Rivaroxaban
Clopidogrel may increase the anticoagulant activities of Rivaroxaban.
Romidepsin
The metabolism of Romidepsin can be decreased when combined with Clopidogrel.
Ropinirole
The metabolism of Clopidogrel can be decreased when combined with Ropinirole.
Ropivacaine
The metabolism of Ropivacaine can be decreased when combined with Clopidogrel.
Rosiglitazone
Clopidogrel may increase the anticoagulant activities of Rosiglitazone.
Rosuvastatin
The therapeutic efficacy of Clopidogrel can be increased when used in combination with Rosuvastatin.
Rucaparib
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Rucaparib resulting in a loss in efficacy.
Salicylic Acid
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Salicylic acid.
Saquinavir
The metabolism of Clopidogrel can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Clopidogrel can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Sarilumab.
Secobarbital
The metabolism of Clopidogrel can be increased when combined with Secobarbital.
Selegiline
The metabolism of Selegiline can be decreased when combined with Clopidogrel.
Selexipag
Clopidogrel may increase the anticoagulant activities of Selexipag.
Sertraline
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Sertraline resulting in a loss in efficacy.
Sevoflurane
The metabolism of Sevoflurane can be decreased when combined with Clopidogrel.
Sildenafil
The metabolism of Clopidogrel can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Clopidogrel can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Clopidogrel can be increased when it is combined with Simeprevir.
Sodium Citrate
Clopidogrel may increase the anticoagulant activities of Sodium Citrate.
Sorafenib
The metabolism of Clopidogrel can be decreased when combined with Sorafenib.
ST. JOHN'S WORT EXTRACT
The serum concentration of Clopidogrel can be decreased when it is combined with St. John's Wort.
Streptokinase
Clopidogrel may increase the anticoagulant activities of Streptokinase.
Sulfadiazine
The metabolism of Clopidogrel can be decreased when combined with Sulfadiazine.
Sulfamethoxazole
The metabolism of Clopidogrel can be decreased when combined with Sulfamethoxazole.
Sulfisoxazole
The metabolism of Clopidogrel can be decreased when combined with Sulfisoxazole.
Tamoxifen
The metabolism of Tamoxifen can be decreased when combined with Clopidogrel.
Telaprevir
The metabolism of Clopidogrel can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Clopidogrel can be decreased when combined with Telithromycin.
Temazepam
The metabolism of Temazepam can be decreased when combined with Clopidogrel.
Tenecteplase
Clopidogrel may increase the anticoagulant activities of Tenecteplase.
Tenofovir Disoproxil
The metabolism of Clopidogrel can be decreased when combined with Tenofovir disoproxil.
Teriflunomide
The serum concentration of Clopidogrel can be decreased when it is combined with Teriflunomide.
Testosterone
The metabolism of Testosterone can be decreased when combined with Clopidogrel.
Testosterone Cypionate
The metabolism of Testosterone cypionate can be decreased when combined with Clopidogrel.
Testosterone Enanthate
The metabolism of Testosterone enanthate can be decreased when combined with Clopidogrel.
Testosterone Undecanoate
The metabolism of Testosterone undecanoate can be decreased when combined with Clopidogrel.
Theophylline
The metabolism of Clopidogrel can be decreased when combined with Theophylline.
Theophylline anhydrous
The metabolism of Clopidogrel can be decreased when combined with Theophylline.
Thiotepa
The metabolism of Clopidogrel can be decreased when combined with Thiotepa.
Ticagrelor
The metabolism of Clopidogrel can be decreased when combined with Ticagrelor.
Ticlopidine
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Ticlopidine resulting in a loss in efficacy.
Tinzaparin
Clopidogrel may increase the anticoagulant activities of Tinzaparin.
Tinzaparin sodium
Clopidogrel may increase the anticoagulant activities of Tinzaparin.
Tipranavir
Tipranavir may increase the antiplatelet activities of Clopidogrel.
Tirofiban
Tirofiban may increase the anticoagulant activities of Clopidogrel.
Tocilizumab
The serum concentration of Clopidogrel can be decreased when it is combined with Tocilizumab.
Tolbutamide
The metabolism of Clopidogrel can be decreased when combined with Tolbutamide.
Tolfenamic Acid
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Tolfenamic Acid.
Topiramate
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Topiramate resulting in a loss in efficacy.
Tositumomab
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Tositumomab.
Tramadol
The metabolism of Tramadol can be decreased when combined with Clopidogrel.
Tranilast
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Tranilast.
Tranylcypromine
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Tranylcypromine resulting in a loss in efficacy.
Trapidil
Trapidil may increase the anticoagulant activities of Clopidogrel.
Treprostinil
Clopidogrel may increase the anticoagulant activities of Treprostinil.
Tretinoin
The metabolism of Tretinoin can be decreased when combined with Clopidogrel.
Triflusal
Clopidogrel may increase the anticoagulant activities of Triflusal.
Trimebutine
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Trimebutine.
Trimethadione
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Trimethadione.
Trimethoprim
The metabolism of Clopidogrel can be decreased when combined with Trimethoprim.
Trisodium Citrate Anhydrous
Clopidogrel may increase the anticoagulant activities of Sodium Citrate.
Trolamine Salicylate
The risk or severity of adverse effects can be increased when Clopidogrel is combined with Trolamine salicylate.
Troxerutin
Clopidogrel may increase the anticoagulant activities of Troxerutin.
Urokinase
Clopidogrel may increase the anticoagulant activities of Urokinase.
Valproate
The metabolism of Clopidogrel can be decreased when combined with Valproic Acid.
Valproic Acid
The metabolism of Clopidogrel can be decreased when combined with Valproic Acid.
Valsartan
The metabolism of Clopidogrel can be decreased when combined with Valsartan.
Velpatasvir
The metabolism of Velpatasvir can be decreased when combined with Clopidogrel.
Vemurafenib
The serum concentration of Clopidogrel can be increased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Clopidogrel can be decreased when combined with Venlafaxine.
Verapamil
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Verapamil.
Vinpocetine
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Vinpocetine.
Vitamin E
Vitamin E may increase the antiplatelet activities of Clopidogrel.
Vorapaxar
Clopidogrel may increase the anticoagulant activities of Vorapaxar.
Voriconazole
The serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Voriconazole resulting in a loss in efficacy.
Vortioxetine
The metabolism of Vortioxetine can be decreased when combined with Clopidogrel.
Warfarin
Clopidogrel may increase the anticoagulant activities of Warfarin.
Zafirlukast
The metabolism of Clopidogrel can be decreased when combined with Zafirlukast.
Ziconotide
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Ziconotide.
Ziprasidone
The metabolism of Clopidogrel can be decreased when combined with Ziprasidone.
Zonisamide
The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Zonisamide.
